These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15718230)

  • 1. Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid {beta} peptide.
    Raman B; Ban T; Yamaguchi K; Sakai M; Kawai T; Naiki H; Goto Y
    J Biol Chem; 2005 Apr; 280(16):16157-62. PubMed ID: 15718230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
    Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
    J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
    Tahmasebinia F; Emadi S
    Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
    Mancino AM; Hindo SS; Kochi A; Lim MH
    Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity.
    White AR; Du T; Laughton KM; Volitakis I; Sharples RA; Xilinas ME; Hoke DE; Holsinger RM; Evin G; Cherny RA; Hill AF; Barnham KJ; Li QX; Bush AI; Masters CL
    J Biol Chem; 2006 Jun; 281(26):17670-80. PubMed ID: 16648635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity.
    Crouch PJ; Savva MS; Hung LW; Donnelly PS; Mot AI; Parker SJ; Greenough MA; Volitakis I; Adlard PA; Cherny RA; Masters CL; Bush AI; Barnham KJ; White AR
    J Neurochem; 2011 Oct; 119(1):220-30. PubMed ID: 21797865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
    Rana M; Sharma AK
    Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
    Cherny RA; Atwood CS; Xilinas ME; Gray DN; Jones WD; McLean CA; Barnham KJ; Volitakis I; Fraser FW; Kim Y; Huang X; Goldstein LE; Moir RD; Lim JT; Beyreuther K; Zheng H; Tanzi RE; Masters CL; Bush AI
    Neuron; 2001 Jun; 30(3):665-76. PubMed ID: 11430801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
    Abelein A; Gräslund A; Danielsson J
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5407-12. PubMed ID: 25825723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual stimulation of beta-amyloid fibrillogenesis by clioquinol and divalent metals.
    Bolognin S; Zatta P; Drago D; Tognon G; Parnigotto PP; Ricchelli F
    Neuromolecular Med; 2008; 10(4):322-32. PubMed ID: 18712494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal chelator decreases Alzheimer beta-amyloid plaques.
    Gouras GK; Beal MF
    Neuron; 2001 Jun; 30(3):641-2. PubMed ID: 11430794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
    Faller P; Hureau C; La Penna G
    Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence.
    Garzon-Rodriguez W; Yatsimirsky AK; Glabe CG
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2243-8. PubMed ID: 10465554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Dynamics Study on the Inhibition Mechanisms of Drugs CQ1-3 for Alzheimer Amyloid-β40 Aggregation Induced by Cu(2.).
    Dong M; Li H; Hu D; Zhao W; Zhu X; Ai H
    ACS Chem Neurosci; 2016 May; 7(5):599-614. PubMed ID: 26871000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
    Summers KL; Roseman G; Schilling KM; Dolgova NV; Pushie MJ; Sokaras D; Kroll T; Harris HH; Millhauser GL; Pickering IJ; George GN
    Inorg Chem; 2022 Sep; 61(37):14626-14640. PubMed ID: 36073854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of multitarget-directed selenium-containing clioquinol derivatives for the treatment of Alzheimer's disease.
    Wang Z; Wang Y; Li W; Mao F; Sun Y; Huang L; Li X
    ACS Chem Neurosci; 2014 Oct; 5(10):952-62. PubMed ID: 25121395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity.
    Matlack KE; Tardiff DF; Narayan P; Hamamichi S; Caldwell KA; Caldwell GA; Lindquist S
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4013-8. PubMed ID: 24591589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease.
    House E; Collingwood J; Khan A; Korchazkina O; Berthon G; Exley C
    J Alzheimers Dis; 2004 Jun; 6(3):291-301. PubMed ID: 15201484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy.
    Ferrada E; Arancibia V; Loeb B; Norambuena E; Olea-Azar C; Huidobro-Toro JP
    Neurotoxicology; 2007 May; 28(3):445-9. PubMed ID: 17382398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metallobiology of Alzheimer's disease.
    Bush AI
    Trends Neurosci; 2003 Apr; 26(4):207-14. PubMed ID: 12689772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.